A 12-week Pilates Programme for Low Back Pain: Perceived and Actual Outcomes
- Disease/Condition
- Low Back Pain
- Drug/Device/Intervention
- Pilates Group
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- University of Malta
- Phase
- N/A
- Start date
- Jun 01, 2024
- End date
- Aug 01, 2025
- Enrollment
- 90 participants
Questionnaire 1,Questionnaire 2
Pilates has emerged as a prominent exercise therapy gaining recognition among healthcare
 professionals for its potential benefits in managing low back pain (LBP). As healthcare
 practitioners increasingly incorporate Pilates into clinical practice, understanding its
 effects on LBP becomes crucial. This study explores the rationale behind Pilates as a
 therapeutic intervention for LBP, its diverse applications, varying programme durations, and
 the significance of long-term follow-ups. Through an examination of existing studies, the aim
 is to unravel the nuanced impact of Pilates on pain intensity, functional disability, and
 overall quality of life for individuals experiencing LBP. Furthermore, this study addresses
 gaps in current research, guiding the way for an extended exploration into the ideal duration
 of Pilates programmes and the implications of sustained, long-term engagement.
 
 Throughout this research study, the following research question was adopted: What is the
 perception and actual outcomes of a Pilates programme in the management of LBP in the short
 and long term?
 
 The null hypothesis (H0) for this study was that there is no significant difference following
 a 12 weeks Pilates programme in all outcome measures. The alternative hypothesis (H1) stated
 that there is significant difference in outcomes following a 12-week Pilates programme in the
 management of LBP.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06395493
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06395493 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Malta and is currently Not yet recruiting. The study focuses on Low Back Pain. Target enrollment is 90 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.